81
Views
7
CrossRef citations to date
0
Altmetric
Miscellaneous

Targeting the myocardial sodium–hydrogen exchange for treatment of heart failure

Pages 291-298 | Published online: 25 Feb 2005

Bibliography

  • WAKABAYASHI S, SHIGEKAWA M, POUYSSEGUR J: Molecular physiology of vertebrate Na±/H+ exchangers. Physiol Rev (1997) 77:51–74.
  • FLIEGEL L, FROHLICH 0: The Na±/H+ exchanger: an update on structure, regulation and cardiac physiology. Biochem. (1993) 296:273–285.
  • ORLOWSKI J, GRINSTEIN S: Na±/H+ exchangers of mammalian cells. I Biol. Chem. (1997) 272:22373–22376.
  • NUMUTA M, PETRECCA K, LAKE N, ORLOWSKI J: Identification of a mitochondrial Na±/H+ exchanger. I Biol. Chem. (1998) 273:6951–6959.
  • NASS R, RAO R: Novel localization of a Na±/H+ exchanger in a late endosomal compartment of yeast. Implications for vacuole biogenesis. j Biol. Chem. (1998) 273:21054–21060.
  • NUMATA M, ORLOWSKI J: Molecularcloning and characterization of a novel (Na±/ K+)/H+ exchanger localized to the trans-Golgi network. I Biol. Chem. (2001) 276:17387–17394.
  • WU ML, VAUGHAN-JONES RD: Interaction between Nat and H+ ions on Na-H exchange in sheep cardiac Purkinje fibers. J. Mai Cell. Cardiol (1997) 29:1131–1140.
  • KINSELLA JL, HELLER P, FROEHLICH JP: Na+/H+ exchanger: proton modifier site regulation of activity. Biochem. Cell. Biol. (1998) 76:743–749.
  • SICZKOWSKI M, NG LL: Phorbol ester activation of the rat vascular myocyte Nei Fl+ exchanger isoform I. Hypertension (1996) 27:859–866.
  • WANG H, SILVA NL, LUCCHESI PA et al.: Phosphorylation and regulation of the Na+/H+ exchanger through mitogen-activated protein kinase. Biochemistry (1997) 29:9151–9158.
  • MOOR AN, FLIEGEL L: Protein kinasemediated regulation of the Na±/H+ exchanger in the rat myocardium by mitogen-activated protein kinase-dependent pathways. Biol. Chem. (1999) 274:22985–22992.
  • KHANDOUDI N, HO J, KARMAZYN M: Role of sodium/hydrogen exchange in mediating the effects of endothelin-1 on the normal and ischemic and reperfused heart. Circ. Res. (1994) 75:369–378.
  • WU ML, TSENG YZ: The modulatory effects of endothelin- I, carbachol and isoprenaline upon Na+-H± exchange in dog cardiac Purkinje fibers. j Physic] (Lmid) (1993) 471:583–597.
  • ITO N, KAGAYA Y, WEINBERG EO, BARRY WH, LORELL BH: Endothelin and angiotensin II stimulation of Na+-H± exchange is impaired in cardiac hypertrophy. j CBI]. Invest. (1997) 99:125–135.
  • MATSUI H, BARRY WH, LIVSEY C, SPITZER KW: Angiotensin II stimulates sodium-hydrogen exchange in adult rabbit ventricular myocytes. Cardiovasc. Res. (1995) 29:215–221.
  • BOSTON DR, KOYAMA T, RODRIGUEZ-LARRAIN J, ZOU A, SU Z, BARRY WH: Effects of angiotensin II on intracellular calcium and contracture in metabolically inhibited cardiomyocytes. Pharmacol Exp. Ther. (1998) 285:716–723.
  • MATTIAZI A, PEREZ NG, VILA-PETROF MG, ALVAREZ B, CAMILION DE HURTADO MC, CINGOLANI HE: Dissociation between positive inotropic and alkalinizing effects of angiotensin II in feline myocardium. Am. Physic] (1997) 272:H1131–H1136.
  • WALLERT MA, FROHLICH 0:13i-adrenergic stimulation of the Na-H exchange in cardiac myocytes. Am. Physic] (1992) 263:C1096–C1102.
  • PUGEAT M, VASSORT G: Neurohumoral modulation of intracellular pH in the heart. Cardiovasc. Res. (1995) 29:178–183.
  • YOKOYAMA H, YASUTAKE M, AVKIRAN M: I31-adrenergic stimulation of sarcolemmal Na+-H+ exchanger activity in rat ventricular myocytes: evidence for selective mediation by the I31A-adrenoceptor subtype. Circ. Res. (1998) 82:1078–1085.
  • WAKABAYASHI S, FAFOURNOUX P, SARDET C, POUYSSEGUR J: The Nat/ 1-1+ antiporter cytoplasmic domain mediates growth factor signals and controls H' sensing. Proc. Natl. Acad. Li. USA (1992) 89:2424–2428.
  • SABRI A, BYRON KL, SAMAREL AM, BELL J, LUCCHESI PA: Hydrogen peroxide activates mitogen-activated protein kinases and Na+-H± exchange in neonatal rat cardiac myocytes. Circ. Res. (1998) 82:1053–1062.
  • HOQUE ANE, HAIST JV, KARMAZYN M: Na+-H+ exchange inhibition protects against mechanical, ultrastructural and biochemical impairment induced by low concentrations of lysophosphatidylcholine in isolated rat hearts. Circ. Res. (1997) 80:95–102.
  • PEREZ NG, ALVAREZ BV, CAMILION DE HURTADO MC, CINGOLANI HE: pHi regulation in myocardium of the spontaneously hypertensive rat. Compensated enhanced activity of the Nat-Fl+ exchanger. Circ. Res. (1995) 77:1192–1200.
  • SCHUSSHEIM AE, RADDA GK: Altered Na+-H+ exchange activity in the spontaneously hypertensive perfused rat heart. j Mal Cell. Cardiol. (1995) 27:1475–1481.
  • ENNIS IL, ALVAREZ BV, CAMILION DE HURTADO MC, CINGOLANI HE: Enalapril induces regression of cardiac hypertrophy and normalization of pHi regulatory mechanisms. Hypertension (1998) 31:961–967.
  • YOKOYAM H, GUNSSEGARAM S, HARDING SE, AVKIRAN M: Sarcolemmal Na±/H+ exchanger activity and expression in human ventricular myocardium. I Am. Coll. Cardiol. (2000) 36:534–540.
  • •First demonstration of increased NHE-1 activity in clinical heart failure.
  • GAN XT, CHAKRABARTI S, KARMAZYN M: Modulation of Na±/H+ exchange isoform 1 mRNA expression in isolated rat hearts. Am. j Physiol. (1999) 277(3 Pt 2):H993–H998.
  • CHEN L, GAN XT, HAIST JV, FENG Q,LU X, CHAKRABARTI S, KARMAZYN M: Attenuation of compensatory right ventricular hypertrophy and heart failure following monocrotaline-induced pulmonary vascular injury by the Na+-H+ exchange inhibitor cariporide. j Pharmacol Exp. Ther. (2001) 298:469–476.
  • •First demonstration of beneficial effects of NHE-1 inhibition in a noninfarction heart failure model.
  • SANDMANN S, YU M, KASCHINA E et al: Differential effects of angiotensin and AT2 receptors on the expression, translation and function of the Nat-H± exchanger and Na+-HCO3_ symporter in the rat heart after myocardial infarction. j Am. Coll Cardiol (2001) 37:2154–2165.
  • •Strong evidence for contribution of the Ang II system to upregulation of NHE-1 after infarction.
  • KARMAZYN M, GAN XT, HUMPHREYS RA, YOSHIDA H, KUSUMOTO K: The myocardial Na+-H+ exchange: structure, regulation, and its role in heart disease. Circ. Res. (1999) 85:777–786.
  • •Thorough review of myocardial NHE-1.
  • KARMAZYN M, SOSTARIC JV, GAN XT: The myocardial Na±/H+ exchanger: a potential therapeutic target for the prevention of myocardial ischaemic and reperfusion injury and attenuation of postinfarction heart failure. Drugs (2001) 61:375–389.
  • •Thorough updated review of myocardial NHE-1 as a target for therapeutic intervention.
  • KARMAZYN M: Pharmacology and clinical assessment of cariporide for the treatment coronary artery diseases. Expert Opiri. Irivestig. Drugs (2000) 9:1099–1108.
  • THEROUX P, CHAITMAN BR, DANCHIN N etal.: Inhibition of the sodium-hydrogen exchanger with cariporide to prevent myocardial infarction in high-risk ischemic situations. Main results of the GUARDIAN trial. Guard during ischemia against necrosis (GUARDIAN) Investigators. Circulation (2000) 102:3032–3038.
  • ZEYMER U, SURYAPRANATA H, MONASSIER JP etal.: The Na+/H+ exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction. Results of the Evaluation of the Safety and Cardioprotective effects of eniporide in Acute Myocardial Infarction (ESCAMI) trial. Am. Coll. Cardiol. (2001) 38:1644–1650.
  • RUPPRECHT HJ, VOM DAHL J, TERRES W et al.: Cardioprotective effects of the Na+/H+ exchange inhibitor cariporide in patients with acute anterior myocardial infarctionundergoing direct PTCA. Circulation (2000) 101:2902–2908.
  • AVKIRAN M, MARBER MS: Na+/H+ exchange inhibitors for cardioprotective therapy: progress, problems and prospects. J. Am. Coll Cardiol (2002) 39:747–753.
  • •Evaluation of clinical trials with NHE-1 inhibitors.
  • KATZ AM: Heart failure. In: Pathophysiology, Molecular Biology, and Clinical Management. Lippincott Williams & Wilkins, Philadelphia, USA (2000).
  • •Excellent, beautifully-written and highly readable chapter on heart failure.
  • YAMAZAKI T, KOMURO I, KUDOH S et al.: Role of ion channels and exchanger in mechanical stretch-induced cardiomyocyte hypertrophy. Circ. Res. (1998) 82:430–437.
  • •Strong evidence for NHE-1 as a downstream mediator in hypertrophy.
  • CINGOLANI HE, ALVAREZ BV, ENNIS IL et al.: Stretch-induced alkalinization of feline papillary muscle. An autocrine-paracrine system. Circ. Res. (1998) 83:775–780.
  • •As above.
  • HORI M, NAKATSUBO N, KAGIYA T et al.: The role of Na+/H+ exchange in norepinephrine-induced protein synthesis in neonatal cultured cardiomyocytes. fix]. Circ. J. (1990) 54:535–539.
  • DOSTAL DE, BAKER KM: Angiotensinand endothelin: messengers that couple ventricular stretch to the Na+/H+ exchanger and cardiac hypertrophy. Circ. Res. (1998) 83:870–873.
  • CINGOLANI HE: Na+/H+ exchange hyperactivity and myocardial hypertrophy: are they linked phenomena? Cardiovasc. Res. (1999) 44:462–467.
  • SCHLUTER KD, SCHAFER M, BALSER C, TAIMOR G, PIPER HM: Influence of pHi and creatine phosphate on P-adrenoceptor-mediated cardiac hypertrophy. J. Ma. Cell. Cardiol (1998) 30:763–771.
  • HASEGAWA S, NAKANO M, TANIGUCHI Y, IMAI S, MURATA K, SUZUKI T: Effects of Na+-H+ exchange blocker amiloride on left ventricular remodeling after anterior myocardial infarction in rats. Cardiovasc. Drugs Ther. (1995) 9:823–826.
  • TANIGUCHI Y, NAKANO M, HASEGAWA S et al.: Beneficial effect of amiloride, a Na+-H+ exchange blocker, in a murine model of dilated cardiomyopathy. Res. Commun. Chem. Pathol. Pharmacol (1996) 92:201–210.
  • YOSHIDA H, KARMAZYN M: Na±/H+ exchange inhibition attenuates hypertrophy and heart failure in 1-wk postinfarction rat myocardium. Am. j Physic] (2000) 278:H300–H304.
  • •Demonstration of the beneficial effects of NHE-1 inhibition in early postinfarction remodelling.
  • KUSUMOTO K, HAIST JV, KARMAZYN M: Na±/H+ exchange inhibition reduces hypertrophy and heart failure after myocardial infarction in rats. Am. j. Physiol (2001) 280:H738–H745.
  • •Demonstration of the beneficial effects of NHE-1 inhibition in postinfarction remodelling and heart failure.
  • SPITZNAGEL H, CHUNG 0, XIA Q et al.: Cardioprotective effects of the Na±/H±exchange inhibitor cariporide in infarct-induced heart failure. Cardiovasc. Res. (2000) 46:102–110.
  • •As above.
  • ENGELHARDT S, HEIN L, LOHSE MJ: Inhibition of Na+-H+ exchange prevents hypertrophy, fibrosis, and heart failure in Pradrenergic receptor transgenic mice. Circ.Res. (2002) 90:814–819.
  • •Demonstration of the beneficial effects of NHE-1 inhibition in a genetic mouse model of heart failure.
  • HAYASAKI-KAJIWARA Y, KITANO Y, IWASAKI T etal.: Na + influx via Na±/H+ exchange activates protein kinase C isozymes delta and epsilon in cultured neonatal rat cardiac myocytes. Ma Cell. Cardiol (1999) 31:1559–1572.
  • LOENNECHEN JP, WISLOFF U, FALCK G, ELLINGSEN 0: Effects of cariporide and losartan on hypertrophy, calcium transients, contractility, and gene expression in congestive heart failure. Circulation (2002) 105:1380–1386.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.